Table 2 Patient characteristics at baseline

From: Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a Phase I study

No. of patients

25

Median age, years (range)

63 (24–79)

Sex, no. of male/female subjects

18/7

Primary tumour site, no. of patients

 Colon

13

 Rectum

6

 Rectosigmoid

6

WHO performance status, no. of patients

 0

7

 1

16

 2

2

Prior surgical resection, no. of patients

 Radical

8

 Palliative

5

 Defunctioned only

1

 None

11

Sites of metastatic disease, no. of patients

 Liver only

10

 LN only

1

 Liver and lung

3

 Liver and LN

1

 Lung and LN

2

 Liver, lung and LN

4

 Pelvic disease only

2

 Pelvic and liver

1

 Pelvic and LN

1

No. of measurable lesions (no. of patients)

 1

3

 2

1

3

21

  1. LN=lymph node; WHO=World Health Organisation.